APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,662,814 | +36.3% | 149,976 | -1.3% | 0.07% | +25.9% |
| Q1 2023 | $10,025,590 | +152.2% | 151,995 | +97.7% | 0.05% | +134.8% |
| Q4 2022 | $3,975,517 | +995.2% | 76,881 | +1346.8% | 0.02% | +1050.0% |
| Q3 2022 | $363,000 | -18.4% | 5,314 | -43.5% | 0.00% | 0.0% |
| Q4 2021 | $445,000 | -82.6% | 9,406 | -87.9% | 0.00% | -84.6% |
| Q3 2021 | $2,554,000 | +119.4% | 77,495 | +320.7% | 0.01% | +116.7% |
| Q2 2021 | $1,164,000 | – | 18,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |